Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Operating Leases (2019 - 2025)

Cresco Labs (CRLBF) has disclosed Operating Leases for 6 consecutive years, with $155.3 million as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Operating Leases fell 5.17% year-over-year to $155.3 million, compared with a TTM value of $155.3 million through Dec 2024, down 5.17%, and an annual FY2024 reading of $155.3 million, down 5.17% over the prior year.
  • Operating Leases was $155.3 million for Q4 2024 at Cresco Labs, down from $163.8 million in the prior quarter.
  • Across five years, Operating Leases topped out at $173.3 million in Q4 2022 and bottomed at $74.5 million in Q4 2020.
  • Average Operating Leases over 5 years is $137.2 million, with a median of $155.3 million recorded in 2024.
  • The sharpest move saw Operating Leases decreased 10.12% in 2020, then soared 59.71% in 2021.
  • Year by year, Operating Leases stood at $74.5 million in 2020, then surged by 59.71% to $118.9 million in 2021, then surged by 45.75% to $173.3 million in 2022, then decreased by 5.5% to $163.8 million in 2023, then fell by 5.17% to $155.3 million in 2024.
  • Business Quant data shows Operating Leases for CRLBF at $155.3 million in Q4 2024, $163.8 million in Q4 2023, and $173.3 million in Q4 2022.